Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat.
about
Behavioral and molecular analysis of nicotine-conditioned place preference in zebrafishbPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.Cellular events in nicotine addiction.Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway.Targeting nicotinic receptors for Parkinson's disease therapy.Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and functionFunctional alpha7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata.Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.Striatal dopamine transmission is reduced after chronic nicotine with a decrease in α6-nicotinic receptor control in nucleus accumbens.Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.
P2860
Q28534828-C99B739A-84FB-4288-8C01-572026FB3FDEQ34919642-A0E94914-39CE-4378-A824-4CA53DF7271AQ37247103-EF903410-06F2-4822-8835-E88692327A8DQ37413060-5F1EEA65-B5C6-43B7-9859-F96890C45A61Q37454529-E0D61E74-5954-4615-92E8-6F15EDF65BB0Q37916643-9A20D9C3-E80A-43FD-B63D-DE5DA9FE4E69Q39850502-5608194E-3500-4B72-A67D-961064C72256Q42525257-9FAD567F-1B31-4BA6-8DC1-EF40316D57F1Q42972130-36D3CFEF-4FCD-4AC8-BB33-3DC873A6BD41Q46238789-5321BECF-A2D5-4043-9958-BA63F87F34D7Q48911423-8C2942D9-143B-4166-A28A-AC9D9BA9FD04
P2860
Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Chronic pre-treatment with nic ...... igra pars compacta of the rat.
@en
Chronic pre-treatment with nic ...... igra pars compacta of the rat.
@nl
type
label
Chronic pre-treatment with nic ...... igra pars compacta of the rat.
@en
Chronic pre-treatment with nic ...... igra pars compacta of the rat.
@nl
prefLabel
Chronic pre-treatment with nic ...... igra pars compacta of the rat.
@en
Chronic pre-treatment with nic ...... igra pars compacta of the rat.
@nl
P1433
P1476
Chronic pre-treatment with nic ...... nigra pars compacta of the rat
@en
P2093
Mitchell SN
O'Neill MJ
P356
10.1016/J.NEUROPHARM.2005.07.013
P577
2005-09-08T00:00:00Z